Loading...

Amphastar Pharmaceuticals, Inc.

AMPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$21.41
$0.40(1.90%)
U.S. Market opens in NaNh NaNm

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview

Explore Amphastar Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap971.4M
P/E Ratio9.94
EPS (TTM)$2.03
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$20.79
3 Months$30.37
1 Year Target$11.50

AMPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amphastar Pharmaceuticals, Inc. (AMPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.94 and a market capitalization of 971.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.90%
5-Day Change
-3.47%
1-Month Change
11.34%
3-Month Change
-17.40%
6-Month Change
-12.68%
Year-to-Date (YTD) Change
-20.05%
1-Year Change
-11.05%
3-Year Change
-47.67%
5-Year Change
23.61%
All-Time (Max) Change
144.69%

Contact Information

https://www.amphastar.com
909 980 9484
11570 6th Street, Rancho Cucamonga, CA, 91730

Company Facts

2,028 Employees
IPO DateJun 25, 2014
CountryUS
Actively Trading

Frequently Asked Questions